Evidence map›Paper›PMID 26975510›Full record

ArticleMicrobiome2016

Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.

Caroline Vincent, Mark A Miller, Thaddeus J Edens, Sudeep Mehrotra, Ken Dewar, Amee R Manges

Open access · goldAbstract read
In one paragraph

Article in Microbiome, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  3. Trial
  4. Dissecting the Ecological Structure of Health and Disease in the Global Gut Microbiome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Overcoming toxicity: How nonantagonistic microbes manage to thrive in boom-and-bust environments.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Low Incidence ofOpen forum infectious diseases · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pathogens (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Microorganisms · 2024
    Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Caroline VincentDepartment of Microbiology and Immunology, McGill University, Montréal, Québec, Canada.
Mark A MillerJewish General Hospital, Montréal, Québec, Canada.
Thaddeus J EdensDevil's Staircase Consulting, North Vancouver, British Columbia, Canada.
Sudeep MehrotraNew York Genome Center, New York, NY, USA.
Ken DewarGénome Québec Innovation Centre, McGill University, Montréal, Québec, Canada.
Amee R MangesSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. amee.manges@ubc.ca.
McGill University · CAJewish General Hospital · CANew York Genome Center · USUniversity of British Columbia · CA

Funding

Canadian Institutes of Health Research GSD-113375
6 · The paper itself

Abstract

backgroundClostridium difficile infection (CDI) is the leading infectious cause of nosocomial diarrhea. Hospitalized patients are at increased risk of developing CDI because they are exposed to C. difficile spores through contact with the hospital environment and often receive antibiotics and other medications that can disrupt the integrity of the indigenous intestinal microbiota and impair colonization resistance. Using whole metagenome shotgun sequencing, we examined the diversity and composition of the fecal microbiota in a prospective cohort study of 98 hospitalized patients.

resultsFour patients had asymptomatic C. difficile colonization, and four patients developed CDI. We observed dramatic shifts in the structure of the gut microbiota during hospitalization. In contrast to CDI cases, asymptomatic patients exhibited elevated relative abundance of potentially protective bacterial taxa in their gut at the onset of C. difficile colonization. Use of laxatives was associated with significant reductions in the relative abundance of Clostridium and Eubacterium; species within these genera have previously been shown to enhance resistance to CDI via the production of secondary bile acids. Cephalosporin and fluoroquinolone exposure decreased the frequency of Clostridiales Family XI Incertae Sedis, a bacterial family that has been previously associated with decreased CDI risk.

conclusionsThis study underscores the detrimental impact of antibiotics as well as other medications, particularly laxatives, on the intestinal microbiota and suggests that co-colonization with key bacterial taxa may prevent C. difficile overgrowth or the transition from asymptomatic C. difficile colonization to CDI.

Indexed as

MetagenomeAgedAnti-Bacterial AgentsBile Acids and SaltsCephalosporinsClostridioides difficileCross InfectionDiarrheaEnterocolitis, PseudomembranousEubacteriumFemaleFluoroquinolonesGastrointestinal MicrobiomeHumansLaxativesMaleAnti-Bacterial AgentsBile Acids and SaltsCephalosporinsFluoroquinolonesLaxativesAntimicrobialsClostridium difficile infectionIntestinal microbiotaMedicationsWhole metagenome shotgun sequencing

Identifiers

PMID26975510
PMCPMC4791782
OpenAlexW2299465765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.